Method and composition for regulating the activity of regulatory t cells
CA 2494274 A1 · Owner: Immunofrontier, Inc. · Inventors: Shiku, Hiroshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a composition for regulating the activity of regulatory T cells and a regulation method. Namely a composition containing , an antigen recognized by CD4+CD25+ regulatory T cells or an expression vector encoding the antigen and a method of regulating an immune response of a mammal by administering the composition to the mammal. Thus means useful in , preventing and treating autoimmune diseases and allergic diseases and inhibiting rejection reaction and graft-versus-host reaction in transplantation is provided. Furthermore the immunosuppressive state is , relieved by administering interferon .gamma. or administering a combination of interleukin 12 with …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.